Large And Small-scale Bioprocessing Market 2033: Single-use Systems Steal the Spotlight
The global large and small-scale bioprocessing market was valued at USD 80.5 billion in 2024 and is projected to reach USD 228.7 billion by 2033, expanding at a CAGR of 11.86% from 2025 to 2033. This robust growth is primarily driven by rising global demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies. Biopharmaceutical manufacturers continue to increase investments in flexible production platforms such as single-use systems and modular bioprocessing units, which help shorten development timelines and optimize manufacturing costs. Key Market Trends & Insights North America dominated the global large and small-scale bioprocessing market with a 34.84% share in 2024. The U.S. led within North America due to its advanced biopharmaceutical manufacturing capacity. By workflow, downstream processing accounted for the largest share at 46.85% in 2024. By product, bioreactors/fermenters represented the leading segment with 29.10% market share i...